Storia in 20 fonti

FDA approves breakthrough drug for metastatic pancreatic cancer: 'A real revolution'

After decades of efforts to block the tumor-driving RAS protein, the FDA approved daraxonrasib after unprecedented survival gains in metastatic pancreatic cancer; treatment costs about NIS 90,000 a month, raising access concerns

Raccontata da

jpost.com+8 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

ynetnews.comStai leggendo18 h fa

FDA approves breakthrough drug for metastatic pancreatic cancer: 'A real revolution'

originale

Timeline cronologica

mercoledì 26 agosto 2026·forbes.com
FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque
Rasonque joins a short list of treatment options for one of the country’s deadliest types of cancer.
mercoledì 26 agosto 2026·healio.com
Rasonque nabs FDA approval for previously treated metastatic pancreatic adenocarcinoma
The FDA has approved a first-in-class targeted therapy for adults with metastatic pancreatic adenocarcinoma. Daraxonrasib (Rasonque, Revolution Medicines), an RAS inhibitor,…

FDA approves breakthrough drug for metastatic pancreatic cancer: 'A real revolution'

Confronto fonti

FDA approves breakthrough drug for metastatic pancreatic cancer: 'A real revolution'

Timeline cronologica

FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque

Rasonque nabs FDA approval for previously treated metastatic pancreatic adenocarcinoma

FDA approves breakthrough drug to treat advanced pancreatic cancer

FDA approves landmark pancreatic cancer drug

FDA approves pancreatic cancer drug that nearly doubles survival time

FDA approves ‘game-changing’ pancreatic cancer drug

'Grand Slam' Pancreatic Cancer Drug Wins FDA Approval

'Grand Slam' Pancreatic Cancer Drug Wins FDA Approval

FDA approves landmark pancreatic cancer drug that's shown to improve survival

FDA approves new pancreatic cancer drug expected to usher in new era of treatment

FDA approves Revolution Medicines' pancreatic cancer drug, ushering in new era of KRAS therapy

FDA approves breakthrough drug to treat advanced pancreatic cancer

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | CNN

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug

FDA approves landmark pancreatic cancer drug that’s shown to improve survival

Tumore del pancreas, via libera negli Usa alla prima terapia mirata contro il gene killer RAS

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | The Jerusalem Post

New hope for pancreatic cancer patients after FDA approves drug to improve survival

FDA approves ‘game-changing’ pancreatic cancer drug

FDA approves Revolution Medicines' daraxonrasib for pancreatic cancer

Revolution Medicines Wins FDA Nod for First-Of-Its-Kind Pancreatic Cancer Drug - Revolution Medicines (NA

FDA Approves Landmark Pancreatic Cancer Drug That's Shown To Improve Survival

FDA approves breakthrough pancreatic cancer drug proven to extend survival

FDA approves new pancreatic cancer drug that could extend patients' lives

FDA approves new drug Rasonque to treat advanced pancreatic cancer